ASTH (Astrana Health) Quick Ratio: 1.35 (As of Mar. 2026) — 37% Below Median


ASTH Astrana Health Inc ASTH
87 GF Score
Price $43.48
GF Value $82.34
Valuation Significantly Undervalued
! 8 Warning Signs
View Full Analysis

What is Astrana Health Quick Ratio?

Astrana Health ASTH +2.98% 87 Quick Ratio is 1.35 as of Mar. 2026, which is 37% below its 10-year median of 2.13. GuruFocus rates ASTH with a GF Score™ of 87/100 and a GF Value™ of $82.34 (Significantly Undervalued). The stock has 8 warning signs investors should review. Among 683 Healthcare Providers & Services companies, Astrana Health ranks better than 51.54% on this metric.

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Astrana Health's quick ratio for the quarter that ended in Mar. 2026 was 1.35.

Astrana Health has a quick ratio of 1.35. It generally indicates good short-term financial strength.

The historical rank and industry rank for Astrana Health's Quick Ratio or its related term are showing as below:

ASTH' s Quick Ratio Range Over the Past 10 Years
Min: 0.84   Med: 2.13   Max: 3.67
Current: 1.35

During the past 13 years, Astrana Health's highest Quick Ratio was 3.67. The lowest was 0.84. And the median was 2.13.

ASTH's Quick Ratio is ranked better than
51.54% of 683 companies
in the Healthcare Providers & Services industry
Industry Median: 1.32 vs ASTH: 1.35

Astrana Health  (NAS:ASTH) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


Astrana Health Quick Ratio Related Terms


Astrana Health Quick Ratio Historical Data

* Premium members only.

The historical data trend for Astrana Health's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Astrana Health Quick Ratio Chart

Astrana Health Annual Data
Trend Mar16 Mar17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Quick Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.53 2.88 2.11 1.75 1.40

Astrana Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Quick Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.70 1.59 1.40 1.40 1.35

ASTH vs MD, SGRY, ADUS: Quick Ratio Comparison

For the Medical Care Facilities subindustry, Astrana Health's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Astrana Health Quick Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Astrana Health's Quick Ratio distribution charts can be found below:

* The bar in red indicates where Astrana Health's Quick Ratio falls into.


ASTH
87GF Score
Astrana Health Inc ASTH
Quick Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Astrana Health Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

Astrana Health's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Quick Ratio (A: Dec. 2025 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(863.313-0)/615.273
=1.40

Astrana Health's Quick Ratio for the quarter that ended in Mar. 2026 is calculated as

Quick Ratio (Q: Mar. 2026 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(1004.1-0)/745.369
=1.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Quick Ratio →
What does a Quick Ratio of 1.35 mean?
Astrana Health (ASTH) has a Quick Ratio of 1.35 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Astrana Health and its competitors. This is 37% below median its historical median of 2.13. Over the past decade, Astrana Health's Quick Ratio has ranged from 0.84 to 3.67. According to the industry distribution chart, Astrana Health ranks #331 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 48.5%.
Is Astrana Health's Quick Ratio too high?
Astrana Health's current Quick Ratio of 1.35 is 37% below median its 10-year median of 2.13. Over the past 10 years, this metric has ranged from a low of 0.84 to a high of 3.67. The Healthcare Providers & Services industry median Quick Ratio is 1.32. Astrana Health's value of 1.35 is 2.3% above this industry median. Based on the distribution chart, Astrana Health ranks #331 out of 683 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Astrana Health has a GF Score™ of 87/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Astrana Health's Quick Ratio compare to MD and SGRY?
According to the Healthcare Providers & Services industry distribution chart, Astrana Health ranks #331 out of 683 companies for Quick Ratio. This puts Astrana Health in the upper half of its industry. The industry median Quick Ratio is 1.32. Astrana Health's value of 1.35 is 2.3% above this benchmark. Historically, Astrana Health's own Quick Ratio has ranged from 0.84 to 3.67 over the past decade. While the company's 10-year median is 2.13 vs. the industry median of 1.32, Astrana Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Healthcare Providers & Services company?
The median Quick Ratio among Healthcare Providers & Services companies is 1.32, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Astrana Health's current Quick Ratio of 1.35 is 2.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Astrana Health and its competitors. For the Healthcare Providers & Services industry, the median Quick Ratio is 1.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Astrana Health's current Quick Ratio is 1.35, which is 37% below median its own 10-year median of 2.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Astrana Health stock overvalued right now?
Based on GuruFocus' analysis, Astrana Health (ASTH) is currently considered Significantly Undervalued. The stock's GF Value™ is $82.34, compared to a current price of $43.48 — trading 47.2% below its estimated fair value. The current Quick Ratio is 1.35, which is 37% below median its 10-year median of 2.13 and 2.3% above the Healthcare Providers & Services industry median of 1.32. Astrana Health's overall GF Score™ is 87/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Astrana Health (ASTH), the current Quick Ratio is 1.35 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Astrana Health (ASTH) Overvalued in 2026?

Based on GuruFocus' analysis, Astrana Health stock appears to be undervalued. The current stock price of $43.48 is trading 47.2% below its estimated GF Value™ of $82.34. GuruFocus considers Astrana Health to be Significantly Undervalued.

Key valuation signals for ASTH:

  • Quick Ratio: 1.35 (37% below median its 10-year median of 2.13)
  • GF Value™: $82.34 vs. price of $43.48 (47.2% below fair value)
  • GF Score™: 87/100 with 8 warning signs
  • Industry Position: 2.3% above the Healthcare Providers & Services median (#331 of 683)

No single metric tells the full story. See the ASTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Astrana Health Business Description

Other Exchanges 3AM:Germany
Address 1668 South Garfield Avenue, 2nd Floor, Alhambra, CA, USA, 91801
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
87GF Score

Get the complete analysis for ASTH

Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$43.48
Price
$82.34
GF Value